| 1 | [SID24797699] | Active | AC50 | 0.519 | Fluorescence polarization aasay to screen for inhibitors that compete for the binding of FadD28 to a bisubstrate Measured in Biochemical System Using Plate Reader - 2147-01_Inhibitor_Dose_CherryPick_Activity [AID624273, Type: confirmatory] | FATTY-ACID-CoA LIGASE FADD28 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) [Mycobacterium tu [gi:1781172] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 24797699 | | CID | 11839276 | | Outcome | Active | | AC50 | 0.519 [uM] | | BioAssay | Fluorescence polarization aasay to screen for inhibitors that compete for the binding of FadD28 to a bisubstrate Measured in Biochemical System Using Plate Reader - 2147-01_Inhibitor_Dose_CherryPick_Activity | | AID | 624273 | | BioAssay type | confirmatory | | Target | FATTY-ACID-CoA LIGASE FADD28 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) [Mycobacterium tu [gi:1781172] | | PubMed | | | Data Table |  |
|
| 2 | [SID24797699] | Active | IC50 | 6.826 | Dose Response confirmation of uHTS hits for Scp-1 phosphatase using a colorimetric assay [AID540297, Type: confirmatory] | carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 [Homo sapiens] [gi:10864009] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 24797699 | | CID | 11839276 | | Outcome | Active | | IC50 | 6.826 [uM] | | BioAssay | Dose Response confirmation of uHTS hits for Scp-1 phosphatase using a colorimetric assay | | AID | 540297 | | BioAssay type | confirmatory | | Target | carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 [Homo sapiens] [gi:10864009] | | PubMed | | | Data Table |  |
|
| 3 | [SID24797699] | Active | Potency | 25.1189 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 24797699 | | CID | 11839276 | | Outcome | Active | | Potency | 25.1189 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 4 | [SID24797699] | Active | Potency | 25.1189 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 24797699 | | CID | 11839276 | | Outcome | Active | | Potency | 25.1189 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 5 | [SID24797699] | Active | Potency | 28.1838 | qHTS Assay for Inhibitors of DNA Polymerase Beta [AID485314, Type: confirmatory] | DNA polymerase beta [Homo sapiens] [gi:4505931] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 24797699 | | CID | 11839276 | | Outcome | Active | | Potency | 28.1838 [uM] | | BioAssay | qHTS Assay for Inhibitors of DNA Polymerase Beta | | AID | 485314 | | BioAssay type | confirmatory | | Target | DNA polymerase beta [Homo sapiens] [gi:4505931] | | PubMed | | | Data Table |  |
|
| 6 | [SID24797699] | Active | Potency | 28.1838 | qHTS Assay for Inhibitors of DNA Polymerase Beta [AID485314, Type: confirmatory] | DNA polymerase beta [Homo sapiens] [gi:4505931] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 24797699 | | CID | 11839276 | | Outcome | Active | | Potency | 28.1838 [uM] | | BioAssay | qHTS Assay for Inhibitors of DNA Polymerase Beta | | AID | 485314 | | BioAssay type | confirmatory | | Target | DNA polymerase beta [Homo sapiens] [gi:4505931] | | PubMed | | | Data Table |  |
|
| 7 | [SID24797699] | Active | Potency | 35.4813 | qHTS for Inhibitors of Polymerase Eta [AID588591, Type: confirmatory] | DNA polymerase eta [Homo sapiens] [gi:5729982] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 24797699 | | CID | 11839276 | | Outcome | Active | | Potency | 35.4813 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Eta | | AID | 588591 | | BioAssay type | confirmatory | | Target | DNA polymerase eta [Homo sapiens] [gi:5729982] | | PubMed | | | Data Table |  |
|
| 8 | [SID24797699] | Active | Potency | 35.4813 | qHTS for Inhibitors of Polymerase Eta [AID588591, Type: confirmatory] | DNA polymerase eta [Homo sapiens] [gi:5729982] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 24797699 | | CID | 11839276 | | Outcome | Active | | Potency | 35.4813 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Eta | | AID | 588591 | | BioAssay type | confirmatory | | Target | DNA polymerase eta [Homo sapiens] [gi:5729982] | | PubMed | | | Data Table |  |
|
| 9 | [SID24797699] | Active | Potency | 44.6684 | qHTS Assay for Inhibitors of BAZ2B [AID504333, Type: confirmatory] | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 24797699 | | CID | 11839276 | | Outcome | Active | | Potency | 44.6684 [uM] | | BioAssay | qHTS Assay for Inhibitors of BAZ2B | | AID | 504333 | | BioAssay type | confirmatory | | Target | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] | | PubMed | | | Data Table |  |
|
| 10 | [SID24797699] | Active | Potency | 50.1187 | qHTS for Inhibitors of WRN Helicase [AID651768, Type: confirmatory] | WRN [Homo sapiens] [gi:3719421] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 24797699 | | CID | 11839276 | | Outcome | Active | | Potency | 50.1187 [uM] | | BioAssay | qHTS for Inhibitors of WRN Helicase | | AID | 651768 | | BioAssay type | confirmatory | | Target | WRN [Homo sapiens] [gi:3719421] | | PubMed | | | Data Table |  |
|
| 11 | [SID24797699] | Active | Potency | 63.0957 | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain [AID504339, Type: confirmatory] | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 24797699 | | CID | 11839276 | | Outcome | Active | | Potency | 63.0957 [uM] | | BioAssay | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain | | AID | 504339 | | BioAssay type | confirmatory | | Target | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] | | PubMed | | | Data Table |  |
|
| 12 | [SID24797699] | Active | | | 384-well Z-Lyte format Hck-Nef inhibitor HTS run at the PMLSC [AID463187, Type: screening] | |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 24797699 | | CID | 11839276 | | Outcome | Active | | BioAssay | 384-well Z-Lyte format Hck-Nef inhibitor HTS run at the PMLSC | | AID | 463187 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 13 | [SID24797699] | Active | | | Counterscreen for molecules that bind rCAG RNA repeats: fluorescent based biochemical counterscreen assay for inhibitors of the DNA-based (5'CAG/3'GTC) TO-PRO-1 dye complex [AID652068, Type: screening] | |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 24797699 | | CID | 11839276 | | Outcome | Active | | BioAssay | Counterscreen for molecules that bind rCAG RNA repeats: fluorescent based biochemical counterscreen assay for inhibitors of the DNA-based (5'CAG/3'GTC) TO-PRO-1 dye complex | | AID | 652068 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 14 | [SID24797699] | Active | | | Fluorescence-based biochemical primary high throughput screening assay to identify molecules that bind r(CAG) RNA repeats [AID651821, Type: screening] | |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 24797699 | | CID | 11839276 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical primary high throughput screening assay to identify molecules that bind r(CAG) RNA repeats | | AID | 651821 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 15 | [SID24797699] | Active | | | Fluorescence-based biochemical high throughput confirmation assay to identify molecules that bind r(CAG) RNA repeats [AID652065, Type: screening] | |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 24797699 | | CID | 11839276 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical high throughput confirmation assay to identify molecules that bind r(CAG) RNA repeats | | AID | 652065 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 16 | [SID24797699] | Active | IC50 | | uHTS fluorescence assay for the identification of Human Immunodeficiency Virus Fusion Inhibitors. [AID1986, Type: confirmatory] | envelope glycoprotein [Human immunodeficiency virus 1] [gi:45357394] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 24797699 | | CID | 11839276 | | Outcome | Active | | IC50 | [uM] | | BioAssay | uHTS fluorescence assay for the identification of Human Immunodeficiency Virus Fusion Inhibitors. | | AID | 1986 | | BioAssay type | confirmatory | | Target | envelope glycoprotein [Human immunodeficiency virus 1] [gi:45357394] | | PubMed | | | Data Table |  |
|
| 17 | [SID24797699] | Active | | | Counterscreen for PME1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay to identify inhibitors of lysophospholipase 2 (LYPLA2). [AID2232, Type: screening] | lysophospholipase II [Homo sapiens] [gi:4581413] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 24797699 | | CID | 11839276 | | Outcome | Active | | BioAssay | Counterscreen for PME1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay to identify inhibitors of lysophospholipase 2 (LYPLA2). | | AID | 2232 | | BioAssay type | screening | | Target | lysophospholipase II [Homo sapiens] [gi:4581413] | | PubMed | | | Data Table |  |
|
| 18 | [SID24797699] | Active | | | Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 2 (LYPLA2). [AID2177, Type: screening] | lysophospholipase II [Homo sapiens] [gi:4581413] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 24797699 | | CID | 11839276 | | Outcome | Active | | BioAssay | Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 2 (LYPLA2). | | AID | 2177 | | BioAssay type | screening | | Target | lysophospholipase II [Homo sapiens] [gi:4581413] | | PubMed | | | Data Table |  |
|
| 19 | [SID24797699] | Active | IC50 | | Fluorescent assay for identification of compounds that inhibit VHR1 [AID1878, Type: confirmatory] | dual specificity protein phosphatase 3 [Homo sapiens] [gi:4758208] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 24797699 | | CID | 11839276 | | Outcome | Active | | IC50 | [uM] | | BioAssay | Fluorescent assay for identification of compounds that inhibit VHR1 | | AID | 1878 | | BioAssay type | confirmatory | | Target | dual specificity protein phosphatase 3 [Homo sapiens] [gi:4758208] | | PubMed | | | Data Table |  |
|
| 20 | [SID24797699] | Active | IC50 | | Fluorescent assay for identification of compounds that inhibit VHR1 [AID1878, Type: confirmatory] | dual specificity protein phosphatase 3 [Homo sapiens] [gi:4758208] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 24797699 | | CID | 11839276 | | Outcome | Active | | IC50 | [uM] | | BioAssay | Fluorescent assay for identification of compounds that inhibit VHR1 | | AID | 1878 | | BioAssay type | confirmatory | | Target | dual specificity protein phosphatase 3 [Homo sapiens] [gi:4758208] | | PubMed | | | Data Table |  |
|
| 21 | [SID24797699] | Active | | | Confirmatory screen for compounds that protect hERG from block by proarrhythmic agents [AID1835, Type: screening] | putative potassium channel subunit [Homo sapiens] [gi:487738] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 24797699 | | CID | 11839276 | | Outcome | Active | | BioAssay | Confirmatory screen for compounds that protect hERG from block by proarrhythmic agents | | AID | 1835 | | BioAssay type | screening | | Target | putative potassium channel subunit [Homo sapiens] [gi:487738] | | PubMed | | | Data Table |  |
|
| 22 | [SID24797699] | Active | | | Confirmatory screen for compounds that protect hERG from block by proarrhythmic agents [AID1835, Type: screening] | putative potassium channel subunit [Homo sapiens] [gi:487738] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 24797699 | | CID | 11839276 | | Outcome | Active | | BioAssay | Confirmatory screen for compounds that protect hERG from block by proarrhythmic agents | | AID | 1835 | | BioAssay type | screening | | Target | putative potassium channel subunit [Homo sapiens] [gi:487738] | | PubMed | | | Data Table |  |
|
| 23 | [SID24797699] | Active | | | Confirmatory screen for compounds that protect hERG from block by proarrhythmic agents [AID1835, Type: screening] | putative potassium channel subunit [Homo sapiens] [gi:487738] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 24797699 | | CID | 11839276 | | Outcome | Active | | BioAssay | Confirmatory screen for compounds that protect hERG from block by proarrhythmic agents | | AID | 1835 | | BioAssay type | screening | | Target | putative potassium channel subunit [Homo sapiens] [gi:487738] | | PubMed | | | Data Table |  |
|
| 24 | [SID24797699] | Active | | | Confirmatory screen for compounds that protect hERG from block by proarrhythmic agents [AID1835, Type: screening] | putative potassium channel subunit [Homo sapiens] [gi:487738] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 24797699 | | CID | 11839276 | | Outcome | Active | | BioAssay | Confirmatory screen for compounds that protect hERG from block by proarrhythmic agents | | AID | 1835 | | BioAssay type | screening | | Target | putative potassium channel subunit [Homo sapiens] [gi:487738] | | PubMed | | | Data Table |  |
|
| 25 | [SID24797699] | Active | | | Confirmatory screen for compounds that protect hERG from block by proarrhythmic agents [AID1835, Type: screening] | putative potassium channel subunit [Homo sapiens] [gi:487738] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 24797699 | | CID | 11839276 | | Outcome | Active | | BioAssay | Confirmatory screen for compounds that protect hERG from block by proarrhythmic agents | | AID | 1835 | | BioAssay type | screening | | Target | putative potassium channel subunit [Homo sapiens] [gi:487738] | | PubMed | | | Data Table |  |
|
| 26 | [SID92709303] | Active | | | Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition [AID652029, Type: other] | LYPLA2 gene product [Homo sapiens] [gi:9966764] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 92709303 | | CID | 11839276 | | Outcome | Active | | BioAssay | Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition | | AID | 652029 | | BioAssay type | other | | Target | LYPLA2 gene product [Homo sapiens] [gi:9966764] | | PubMed | | | Data Table |  |
|
| 27 | [SID92709303] | Active | | | Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition and selectivity [AID652030, Type: other] | LYPLA2 gene product [Homo sapiens] [gi:9966764] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 92709303 | | CID | 11839276 | | Outcome | Active | | BioAssay | Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition and selectivity | | AID | 652030 | | BioAssay type | other | | Target | LYPLA2 gene product [Homo sapiens] [gi:9966764] | | PubMed | | | Data Table |  |
|
| 28 | [SID92709303] | Active | | | Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition and selectivity [AID652030_1, Type: other] | LYPLA2 gene product [Homo sapiens] [gi:9966764] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 92709303 | | CID | 11839276 | | Outcome | Active | | BioAssay | Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition and selectivity | | AID | 652030 | | BioAssay type | other | | Target | LYPLA2 gene product [Homo sapiens] [gi:9966764] | | PubMed | | | Data Table |  |
|
| 29 | [SID24797699] | Active | | | Differential Scanning Fluorimetry (Thermal Shift) Binding Assay for validation of Inhibitors of Scp-1 phosphatase [AID540329, Type: other] | carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 [Homo sapiens] [gi:10864009] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 24797699 | | CID | 11839276 | | Outcome | Active | | BioAssay | Differential Scanning Fluorimetry (Thermal Shift) Binding Assay for validation of Inhibitors of Scp-1 phosphatase | | AID | 540329 | | BioAssay type | other | | Target | carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 [Homo sapiens] [gi:10864009] | | PubMed | | | Data Table |  |
|
| 30 | [SID24797699] | Active | | | Fluorescence polarization to screen for inhibitor that competite the binding of FadD28 to bisubstrate Measured in Biochemical System Using Plate Reader - 2147-01_Inhibitor_SinglePoint_HTS_Activity [AID588549, Type: screening] | FATTY-ACID-CoA LIGASE FADD28 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) [Mycobacterium tu [gi:1781172] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 24797699 | | CID | 11839276 | | Outcome | Active | | BioAssay | Fluorescence polarization to screen for inhibitor that competite the binding of FadD28 to bisubstrate Measured in Biochemical System Using Plate Reader - 2147-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 588549 | | BioAssay type | screening | | Target | FATTY-ACID-CoA LIGASE FADD28 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) [Mycobacterium tu [gi:1781172] | | PubMed | | | Data Table |  |
|
| 31 | [SID24797699] | Active | | | Small Molecule Inhibitors of FGF22-Mediated Excitatory Synaptogenesis & Epilepsy Measured in Biochemical System Using RT-PCR - 7012-01_Inhibitor_SinglePoint_HTS_Activity [AID651658, Type: screening] | FGF22 gene product [Homo sapiens] [gi:10190672] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 24797699 | | CID | 11839276 | | Outcome | Active | | BioAssay | Small Molecule Inhibitors of FGF22-Mediated Excitatory Synaptogenesis & Epilepsy Measured in Biochemical System Using RT-PCR - 7012-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 651658 | | BioAssay type | screening | | Target | FGF22 gene product [Homo sapiens] [gi:10190672] | | PubMed | | | Data Table |  |
|
| 32 | [SID92709303] | Active | | | Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition and selectivity [AID652030_2, Type: other] | lysophospholipase 2 [Mus musculus] [gi:123122209] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 92709303 | | CID | 11839276 | | Outcome | Active | | BioAssay | Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition and selectivity | | AID | 652030 | | BioAssay type | other | | Target | lysophospholipase 2 [Mus musculus] [gi:123122209] | | PubMed | | | Data Table |  |
|
| 33 | [SID24797699] | Active | | | Single concentration confirmation of uHTS hits for Scp-1 phosphatase using a colorimetric assay [AID540281, Type: screening] | carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 [Homo sapiens] [gi:10864009] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 24797699 | | CID | 11839276 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS hits for Scp-1 phosphatase using a colorimetric assay | | AID | 540281 | | BioAssay type | screening | | Target | carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 [Homo sapiens] [gi:10864009] | | PubMed | | | Data Table |  |
|
| 34 | [SID24797699] | Active | | | uHTS Colorimetric assay for identification of inhibitors of Scp-1 [AID493091, Type: screening] | carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 [Homo sapiens] [gi:10864009] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 24797699 | | CID | 11839276 | | Outcome | Active | | BioAssay | uHTS Colorimetric assay for identification of inhibitors of Scp-1 | | AID | 493091 | | BioAssay type | screening | | Target | carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 [Homo sapiens] [gi:10864009] | | PubMed | | | Data Table |  |
|
| 35 | [SID24797699] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 24797699 | | CID | 11839276 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 36 | [SID24797699] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 24797699 | | CID | 11839276 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 37 | [SID24797699] | Inactive | Potency | | qHTS of alpha-syn Inhibitors [AID652106, Type: confirmatory] | Alpha-synuclein [gi:586067] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 24797699 | | CID | 11839276 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of alpha-syn Inhibitors | | AID | 652106 | | BioAssay type | confirmatory | | Target | Alpha-synuclein [gi:586067] | | PubMed | | | Data Table |  |
|
| 38 | [SID24797699] | Inactive | Potency | | qHTS of alpha-syn Inhibitors [AID652106, Type: confirmatory] | Alpha-synuclein [gi:586067] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 24797699 | | CID | 11839276 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of alpha-syn Inhibitors | | AID | 652106 | | BioAssay type | confirmatory | | Target | Alpha-synuclein [gi:586067] | | PubMed | | | Data Table |  |
|
| 39 | [SID24797699] | Inactive | | | Primary cell-based high throughput screening assay to measure STAT1 inhibition [AID920, Type: screening] | signal transducer and activator of transcription 1-alpha/beta isoform alpha [Homo sapiens] [gi:6274552] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 24797699 | | CID | 11839276 | | Outcome | Inactive | | BioAssay | Primary cell-based high throughput screening assay to measure STAT1 inhibition | | AID | 920 | | BioAssay type | screening | | Target | signal transducer and activator of transcription 1-alpha/beta isoform alpha [Homo sapiens] [gi:6274552] | | PubMed | | | Data Table |  |
|
| 40 | [SID24797699] | Inactive | | | Primary cell-based high throughput screening assay to measure STAT1 inhibition [AID920, Type: screening] | signal transducer and activator of transcription 1-alpha/beta isoform alpha [Homo sapiens] [gi:6274552] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 24797699 | | CID | 11839276 | | Outcome | Inactive | | BioAssay | Primary cell-based high throughput screening assay to measure STAT1 inhibition | | AID | 920 | | BioAssay type | screening | | Target | signal transducer and activator of transcription 1-alpha/beta isoform alpha [Homo sapiens] [gi:6274552] | | PubMed | | | Data Table |  |
|
| 41 | [SID24797699] | Inactive | | | Primary cell-based high throughput screening assay to measure STAT1 activation [AID932, Type: screening] | signal transducer and activator of transcription 1-alpha/beta isoform alpha [Homo sapiens] [gi:6274552] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 24797699 | | CID | 11839276 | | Outcome | Inactive | | BioAssay | Primary cell-based high throughput screening assay to measure STAT1 activation | | AID | 932 | | BioAssay type | screening | | Target | signal transducer and activator of transcription 1-alpha/beta isoform alpha [Homo sapiens] [gi:6274552] | | PubMed | | | Data Table |  |
|
| 42 | [SID24797699] | Inactive | | | Primary cell-based high throughput screening assay to measure STAT1 activation [AID932, Type: screening] | signal transducer and activator of transcription 1-alpha/beta isoform alpha [Homo sapiens] [gi:6274552] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 24797699 | | CID | 11839276 | | Outcome | Inactive | | BioAssay | Primary cell-based high throughput screening assay to measure STAT1 activation | | AID | 932 | | BioAssay type | screening | | Target | signal transducer and activator of transcription 1-alpha/beta isoform alpha [Homo sapiens] [gi:6274552] | | PubMed | | | Data Table |  |
|
| 43 | [SID24797699] | Inactive | | | Primary cell-based high throughput screening assay to measure STAT3 inhibition [AID862, Type: screening] | STAT3 [Homo sapiens] [gi:13272532] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 24797699 | | CID | 11839276 | | Outcome | Inactive | | BioAssay | Primary cell-based high throughput screening assay to measure STAT3 inhibition | | AID | 862 | | BioAssay type | screening | | Target | STAT3 [Homo sapiens] [gi:13272532] | | PubMed | | | Data Table |  |
|
| 44 | [SID24797699] | Inactive | | | Primary cell-based high throughput screening assay to measure STAT3 inhibition [AID862, Type: screening] | STAT3 [Homo sapiens] [gi:13272532] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 24797699 | | CID | 11839276 | | Outcome | Inactive | | BioAssay | Primary cell-based high throughput screening assay to measure STAT3 inhibition | | AID | 862 | | BioAssay type | screening | | Target | STAT3 [Homo sapiens] [gi:13272532] | | PubMed | | | Data Table |  |
|
| 45 | [SID24797699] | Inactive | | | Primary cell-based high throughput screening assay to measure STAT3 inhibition [AID862, Type: screening] | STAT3 [Homo sapiens] [gi:13272532] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 24797699 | | CID | 11839276 | | Outcome | Inactive | | BioAssay | Primary cell-based high throughput screening assay to measure STAT3 inhibition | | AID | 862 | | BioAssay type | screening | | Target | STAT3 [Homo sapiens] [gi:13272532] | | PubMed | | | Data Table |  |
|
| 46 | [SID24797699] | Inactive | | | Primary cell-based high throughput screening assay to measure STAT3 activation [AID871, Type: screening] | STAT3 [Homo sapiens] [gi:13272532] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 24797699 | | CID | 11839276 | | Outcome | Inactive | | BioAssay | Primary cell-based high throughput screening assay to measure STAT3 activation | | AID | 871 | | BioAssay type | screening | | Target | STAT3 [Homo sapiens] [gi:13272532] | | PubMed | | | Data Table |  |
|
| 47 | [SID24797699] | Inactive | | | Primary cell-based high throughput screening assay to measure STAT3 activation [AID871, Type: screening] | STAT3 [Homo sapiens] [gi:13272532] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 24797699 | | CID | 11839276 | | Outcome | Inactive | | BioAssay | Primary cell-based high throughput screening assay to measure STAT3 activation | | AID | 871 | | BioAssay type | screening | | Target | STAT3 [Homo sapiens] [gi:13272532] | | PubMed | | | Data Table |  |
|
| 48 | [SID24797699] | Inactive | | | Primary cell-based high throughput screening assay to measure STAT3 activation [AID871, Type: screening] | STAT3 [Homo sapiens] [gi:13272532] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 24797699 | | CID | 11839276 | | Outcome | Inactive | | BioAssay | Primary cell-based high throughput screening assay to measure STAT3 activation | | AID | 871 | | BioAssay type | screening | | Target | STAT3 [Homo sapiens] [gi:13272532] | | PubMed | | | Data Table |  |
|
| 49 | [SID24797699] | Inactive | | | Fluorescence-based biochemical primary high throughput assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe [AID651800, Type: screening] | TCRAV4S1 [Homo sapiens] [gi:2358024] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 24797699 | | CID | 11839276 | | Outcome | Inactive | | BioAssay | Fluorescence-based biochemical primary high throughput assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe | | AID | 651800 | | BioAssay type | screening | | Target | TCRAV4S1 [Homo sapiens] [gi:2358024] | | PubMed | | | Data Table |  |
|
| 50 | [SID24797699] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of COUP-TFII (NR2F2) [AID686940, Type: screening] | NR2F2 gene product [Homo sapiens] [gi:14149746] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 24797699 | | CID | 11839276 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of COUP-TFII (NR2F2) | | AID | 686940 | | BioAssay type | screening | | Target | NR2F2 gene product [Homo sapiens] [gi:14149746] | | PubMed | | | Data Table |  |
|